Details of the Drug

General Information of Drug (ID: DMVUSF3)

Drug Name	Pyrazolopyrimidine derivative 5
Synonyms	PMID28067079-Compound-82
Drug Type	Small molecular drug
Structure
Structure	3D MOL	2D MOL
#Ro5 Violations (Lipinski): 0	Molecular Weight (mw)	392.3
	Logarithm of the Partition Coefficient (xlogp)	2.3
	Rotatable Bond Count (rotbonds)	1
	Hydrogen Bond Donor Count (hbonddonor)	0
	Hydrogen Bond Acceptor Count (hbondacc)	5
Chemical Identifiers	Formula C15H14BrN5OS IUPAC Name (6-bromopyrazolo[1,5-a]pyrimidin-2-yl)-(2-methyl-4,5,7,8-tetrahydro-[1,3]thiazolo[4,5-d]azepin-6-yl)methanone Canonical SMILES CC1=NC2=C(S1)CCN(CC2)C(=O)C3=NN4C=C(C=NC4=C3)Br InChI InChI=1S/C15H14BrN5OS/c1-9-18-11-2-4-20(5-3-13(11)23-9)15(22)12-6-14-17-7-10(16)8-21(14)19-12/h6-8H,2-5H2,1H3 InChIKey PPBYGUATKIHBBC-UHFFFAOYSA-N
Cross-matching ID	PubChem CID 71748080 TTD ID D0M3VE

Molecular Interaction Atlas of This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Metabotropic glutamate receptor 5 (mGluR5)	TTHS256	GRM5_HUMAN	Modulator	[1]

------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA)

Jump to Detail Molecular Interaction Atlas of This Drug

Molecular Expression Atlas of This Drug

Molecule Name	Molecule Type	Gene Name	p-value	Fold-Change	Z-score
Metabotropic glutamate receptor 5 (mGluR5)	DTT	GRM5	9.81E-07	-0.26	-0.54

Molecular Expression Atlas (MEA)

Jump to Detail Molecular Expression Atlas of This Drug

References

1	mGlu5 negative allosteric modulators: a patent review (2013 - 2016).Expert Opin Ther Pat. 2017 Jun;27(6):691-706.